Patents by Inventor Liming Yu

Liming Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030018434
    Abstract: Shoulder corrections are applied to measurements obtained from a multi-component electromagnetic logging tool. An anisotropic resistivity model is obtained using the shoulder corrected data. The process is iterated until a good match is obtained between the shoulder corrected data and the model output.
    Type: Application
    Filed: September 17, 2002
    Publication date: January 23, 2003
    Applicant: Baker Hughes, Inc.
    Inventors: Berthold F. Kriegshauser, Otto N. Fanini, Pravin Gupta, Liming Yu
  • Publication number: 20020173914
    Abstract: Measurements made by a multicomponent logging tool in a borehole are inverted to obtain horizontal and vertical resistivities and formation dip and azimuth angles of a formation traversed by the borehole. The inversion is performed using a generalized Marquardt-Levenberg method. In this generalized Marquardt-Levenberg method, a data objective function is defined that is related to a difference between the model output and the measured data. The iterative procedure involves reducing a global objective function that is the sum of the data objective function and a model objective function related to changes in the model in successive iterations. In an alternate embodiment of the invention, the formation azimuth angle is excluded from the iterative process by using derived relations between the multicomponent measurements.
    Type: Application
    Filed: March 5, 2002
    Publication date: November 21, 2002
    Applicant: Baker Hughes, Inc.
    Inventors: Zhiyi Zhang, Liming Yu, Leonty Abraham Tabarovsky, Berthold Kriegshauser
  • Patent number: 6466872
    Abstract: Shoulder corrections are applied to measurements obtained from a multicomponent electromagnetic logging tool. An anisotropic resistivity model is obtained using the shoulder corrected data. The process is iterated until a good match is obtained between the shoulder corrected data and the model output.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: October 15, 2002
    Assignee: Baker Hughes Incorporated
    Inventors: Berthold F. Kriegshauser, Otto N. Fanini, Pravin Gupta, Liming Yu
  • Patent number: 5908626
    Abstract: Disclosed is a hybrid recombinant protein consisting of human interferon-.beta., and a human immunoglobulin Fc fragment, preferably .gamma.4 chain, joined by a peptide linker comprising the sequence Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser (SEQ ID NO:1).
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: June 1, 1999
    Assignee: Tanox, Inc.
    Inventors: Tse Wen Chang, Liming Yu
  • Patent number: 5739306
    Abstract: Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: September 9, 1996
    Date of Patent: April 14, 1998
    Assignee: Tanox Biosystems, Inc.
    Inventors: Michael S.C. Fung, Bill N.C. Sun, Cecily R.Y. Sun, Young Woo Kim, Liming Yu
  • Patent number: 5731428
    Abstract: Disclosed are immunogens and peptides based on the binding site of gClq-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gClq-R. The sequence of the gClq-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gClq-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: September 6, 1996
    Date of Patent: March 24, 1998
    Assignee: Tanux Biosystems, Inc.
    Inventors: Michael S. C. Fung, Bill N. C. Sun, Cecily R. Y. Sun, Young Woo Kim, Liming Yu
  • Patent number: 5728814
    Abstract: Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ D NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: September 4, 1996
    Date of Patent: March 17, 1998
    Assignee: Tanox Biosystems, Inc.
    Inventors: Michael S. C. Fung, Bill N. C. Sun, Cecily R. Y. Sun, Young Woo Kim, Liming Yu
  • Patent number: 5723125
    Abstract: Disclosed is a hybrid recombinant protein consisting of human interferon, preferably interferon-.alpha. (IFN.alpha.), and human immunoglobulin Fc fragment, preferably .gamma.4 chain, joined by a peptide linker comprising the sequence Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser (SEQ ID NO:1).
    Type: Grant
    Filed: September 25, 1996
    Date of Patent: March 3, 1998
    Assignee: Tanox Biosystems, Inc.
    Inventors: Tse Wen Chang, Liming Yu
  • Patent number: 5691447
    Abstract: Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: November 25, 1997
    Assignee: Tanox Biosystems, Inc.
    Inventors: Michael S. C. Fung, Bill N. C. Sun, Cecily R. Y. Sun, Young Woo Kim, Liming Yu
  • Patent number: 5652333
    Abstract: Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120 and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: September 6, 1996
    Date of Patent: July 29, 1997
    Assignee: Tanox Biosystems, Inc.
    Inventors: Michael S. C. Fung, Bill N. C. Sun, Cecily R. Y. Sun, Young Woo Kim, Liming Yu